
Abivax CEO highlights pipeline assets, including lead HIV drug
Dec 7, 2017
Abivax CEO Dr. Hartmut Ehrlich talks to Scrip senior editor Lucie Ellis about the progress and next development steps for its lead clinical-stage molecule against...
partnering360 will be closed in Q1 2019.
Updates to your partnering history and all profiles are now hosted on partneringONE. You may access your relevant partnering history from any partneringONE event that you are registered to attend. No further updates will be made to partnering360.
The latest Insight articles are now found here.
Big pharma wants you to be happy. After grilling you with 200 questions about your biotech project, sending an army of experts to trample through your data, dragging your team through a grinding due diligence and then running up and down your supply chain, at the end of the day this outsized partner wants to hear you are pleased with the engagement it is proposing.
Abivax CEO Dr. Hartmut Ehrlich talks to Scrip senior editor Lucie Ellis about the progress and next development steps for its lead clinical-stage molecule against...
Bringing healthcare into the digital age would create a greenfield opportunity, opening vast opportunities for devices and drugs. Yet before companies can start open field...
partnering360 is the network for dealmakers in the life science industry. This global community of more than 43,000 is constantly growing, and the partnering opportunities continually updating.
I am interested in discuss Obtaining funding from Chinese VC firm and strategy partner.